Inhibition of obliterative bronchiolitis by platelet-derived growth factor receptor protein-tyrosine kinase inhibitor

By Kallio E.   Koskinen P.   Buchdunger E.   Lemstrom K.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 187-187

Elsevier

Access to resources Recommend Favorite

Superoxide dismutase in development of obliterative bronchiolitis

By Salminen U.-S.   Harjula A.L.J.   Maasilta P.K.   Romanska H.M.   Bishop A.E.   Polak J.M.  

Transplantation Proceedings, Vol. 33, Iss. 4, 2001-06 ,pp. : 2477-2477

Elsevier

Access to resources Recommend Favorite

The role of the beta chemokines in experimental obliterative bronchiolitis

By Farivar A.S.   Krishnadasan B.   Naidu B.V.   Woolley S.M.   Mulligan M.S.  

Experimental and Molecular Pathology, Vol. 75, Iss. 3, 2003-12 ,pp. : 210-216

Elsevier

Access to resources Recommend Favorite

Pirfenidone: a novel antifibrotic agent with implications for the treatment of obliterative bronchiolitis

By Dosanjh A.K.   Wan B.   Throndset W.   Sherwood S.   Morris R.E.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1910-1911

Elsevier

Access to resources Recommend Favorite

Enhanced peroxynitrite decomposition protects against experimental obliterative bronchiolitis

By Naidu B.V.   Farivar A.S.   Woolley S.M.   Fraga C.   Salzman A.L.   Szabo C.   Groves J.T.   Mulligan M.S.  

Experimental and Molecular Pathology, Vol. 75, Iss. 1, 2003-08 ,pp. : 12-17

Elsevier

Access to resources Recommend Favorite